Effect of menatetrenone on bone mineral density and incidence of vertebral fractures in postmenopausal women with osteoporosis: a comparison with the effect of etidronate
References (38)
Calcium supplementation and bone loss: a review of controlled clinical trials
Am J Clin Nutr
(1991)Studies of osteoporosis in Japan
Metabolism
(1990)- et al.
Cyclical etidronate versus sodium fluoride in established postmenopausal osteoporosis: a randomized 3-year trial
Bone
(2000) - et al.
The prevention of early postmenopausal bone loss by cyclical etidronate therapy: a 2-year double-blind, placebo-controlled study
Am J Med
(1997) - et al.
A longitudinal study of the effect of vitamin K2 on bone mineral density in postmenopausal women: a comparative study with vitamin D3 and estrogen-progestin therapy
Maturitas
(1999) - et al.
Age-related changes in cortical bone mass in women: metacarpal bone mass measurement study
J Orthop Sci
(1998) - et al.
Age-related changes in cortical bone mass in men: metacarpal bone mass measurement study
J Orthop Sci
(2000) Vitamin K-dependent formation of bone gla protein (osteocalcin) and its function
Vitam Horm
(1985)Pre-emptive bone strikes in prevention of osteoporosis
Lancet
(1998)- et al.
The effects of etidronate on trabecular bone remodeling in postmenopausal spinal osteoporosis: a randomized study comparing intermittent treatment and an ADFR regime
Bone
(1991)
A 4-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis
Am J Med
Short-term variations in bone remodeling biochemical markers: cyclical etidronate and alendronate effects compared
J Clin Endocrinol Metab
Osteoporosis and its treatment
N Engl J Med
Calcium intake and bone mass: a quantitative review of the evidence
Calcif Tissue Int
Clinical guidelines for the treatment of osteoporosis in Japan
Calcif Tissue Int
A 3-year comparative trial in osteoporosis treatment: effect of combined alfacalcidol and elcatonin
J Bone Miner Metab
Hypovitaminosis D in a sunny country: relation to lifestyle and bone markers
J Bone Miner Res
Comparison of calcitriol treatment with etidronate-calcitriol and calcitonin-calcitriol combinations in Turkish women with postmenopausal osteoporosis: a prospective study
Calcif Tissue Int
Menatetrenone inhibits bone resorption partly through inhibition of PG E2 synthesis in vitro
J Bone Miner Res
Cited by (72)
Effects of vitamin K in postmenopausal women: Mini review
2014, MaturitasCitation Excerpt :None of these three studies evaluated the fracture risk. Isolated effects of MK-4 vs placebo or calcium were evaluated in six RCTs [8–11,13,14]. Molecular improvements were assessed in four of these studies [8,11,13,14]; and improvement on OC was detected in all four studies; however, there are inconsistent results on BAP, NTX, and urinary markers.
Nutrition and Risk for Osteoporosis
2013, Osteoporosis: Fourth EditionIntake of vitamin K1 and K2 and risk of hip fractures: The Hordaland Health Study
2011, BoneCitation Excerpt :No RCTs have been a priori designed to show a difference in hip fractures as the main outcome. In two different studies comparing treatment with menatetrenone (a vitamin K2) to placebo, the treatment groups had fewer vertebral fractures during 2 years of follow-up than controls [35,36]. In a study comparing the fracture preventive effect of calcium compared to calcium and menatetrenone supplementation combined, no difference was found between the groups regarding incidence of clinical fractures (humeral, femoral, radial and high-trauma vertebral fractures) [37].
Vitamin K: Infection, Inflammation, and Auto-Immunity
2024, Journal of Inflammation ResearchVitamin K supplementation and bone mineral density in dialysis: results of the double-blind, randomized, placebo-controlled RenaKvit trial
2023, Nephrology Dialysis Transplantation